질병 관리 시장 : 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global disease management market size is expected to reach USD 49.10 Billion in 2034 from USD 17.16 Billion in 2025, growing at a CAGR of 12.39 during 2026-2034.This market is witnessing significant growth driven by the increasing prevalence of chronic diseases and the need for effective healthcare management solutions. Disease management programs focus on improving patient outcomes through coordinated care, monitoring, and education. The growing emphasis on preventive healthcare and cost reduction is significantly contributing to market expansion.

Major drivers include advancements in digital health technologies, increasing healthcare expenditure, and the rising adoption of remote monitoring solutions. Healthcare providers are implementing disease management programs to improve patient compliance and reduce hospital readmissions. The integration of data analytics and telemedicine is enhancing the effectiveness of these programs.

Looking ahead, the market is expected to benefit from continuous innovation in healthcare delivery models and digital solutions. The adoption of AI and predictive analytics will improve patient care and outcomes. Emerging markets are likely to offer significant growth opportunities due to improving healthcare infrastructure. As the focus on chronic disease management increases, the disease management market is set for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Platform

• iOS
• Android
• Others

By Device

• Smartphones
• Tablets
• Wearables

By Indication

• Obesity
• Cardiovascular Issues
• Mental Health
• Diabetes
• Others

COMPANIES PROFILED

• Fitbit LLC, Healthy.io.Ltd, MyFitnessPal Inc., Noom Inc., Azumio Inc., Medisafe, Sleep Cycle AB, Curable Inc., Bearable Ltd, Omada Health Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DISEASE MANAGEMENT MARKET: BY PLATFORM 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Platform
• 4.2. iOS Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Android Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DISEASE MANAGEMENT MARKET: BY DEVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Device
• 5.2. Smartphones Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Wearables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DISEASE MANAGEMENT MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Obesity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Issues Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Mental Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DISEASE MANAGEMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Platform
  • 7.2.2 By Device
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Platform
  • 7.3.2 By Device
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Platform
  • 7.4.2 By Device
  • 7.4.3 By Indication
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Platform
  • 7.5.2 By Device
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Platform
  • 7.6.2 By Device
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DISEASE MANAGEMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Fitbit LLC
  • 9.2.2 Healthy.io.Ltd
  • 9.2.3 MyFitnessPal Inc
  • 9.2.4 Noom Inc
  • 9.2.5 Azumio Inc
  • 9.2.6 Medisafe
  • 9.2.7 Sleep Cycle AB
  • 9.2.8 Curable Inc
  • 9.2.9 Bearable Ltd
  • 9.2.10 Omada Health Inc